Can you take Trulicity injections for weight loss?
22 December 2025
Trulicity is not an approved treatment for weight loss, but Wegovy and Mounjaro are effective and approved alternatives. Learn more in our guide.
Injectable weight loss medications are getting more popular as a convenient and effective way to lose weight alongside a healthy diet and lifestyle.
The two most commonly prescribed weight loss injections are Wegovy (semaglutide) and Mounjaro (tirzepatide) . These medications are known as 'GLP-1 receptor agonists' – they mimic a natural hormone called 'GLP-1', which is involved in appetite control and blood sugar management.
Trulicity (dulaglutide) is also a GLP-1 receptor agonist. So, it's natural you might wonder whether you can use Trulicity injections for weight loss, too.
Can you use Trulicity injections for weight loss?
The short answer is no. While Trulicity has yielded some weight loss in people with type 2 diabetes,¹ this is not the primary purpose of the drug. Trulicity was designed as a type 2 diabetes drug and is only licensed in the UK for blood sugar control.
That means it shouldn't generally be prescribed for weight loss – and any prescriptions of this nature would be considered 'off-label'. This is when a drug is prescribed for something it isn't licensed for.
Where losing weight is the goal, medical professionals and regulatory bodies recommend using licensed and clinically proven weight loss treatments. That includes Mounjaro and Wegovy.
Why is Trulicity not approved for weight loss?
Regulatory bodies – such as the FDA in the US and the MHRA in the UK – conduct clinical trials to ensure a drug is safe for use.
However, these trials generally focus on one particular use for the drug. Wegovy and Mounjaro, for example, underwent extensive trials that focused explicitly on weight loss as the end goal.² ³
The two most commonly prescribed weight loss injections are Wegovy (semaglutide) and Mounjaro (tirzepatide) . These medications are known as 'GLP-1 receptor agonists' – they mimic a natural hormone called 'GLP-1', which is involved in appetite control and blood sugar management.
Trulicity (dulaglutide) is also a GLP-1 receptor agonist. So, it's natural you might wonder whether you can use Trulicity injections for weight loss, too.
Can you use Trulicity injections for weight loss?
The short answer is no. While Trulicity has yielded some weight loss in people with type 2 diabetes,¹ this is not the primary purpose of the drug. Trulicity was designed as a type 2 diabetes drug and is only licensed in the UK for blood sugar control.
That means it shouldn't generally be prescribed for weight loss – and any prescriptions of this nature would be considered 'off-label'. This is when a drug is prescribed for something it isn't licensed for.
Where losing weight is the goal, medical professionals and regulatory bodies recommend using licensed and clinically proven weight loss treatments. That includes Mounjaro and Wegovy.
Why is Trulicity not approved for weight loss?
Regulatory bodies – such as the FDA in the US and the MHRA in the UK – conduct clinical trials to ensure a drug is safe for use.
However, these trials generally focus on one particular use for the drug. Wegovy and Mounjaro, for example, underwent extensive trials that focused explicitly on weight loss as the end goal.² ³
Trulicity's trials focused on testing the drug as a treatment for type 2 diabetes. During these trials, researchers also looked for changes in weight among participants – but this wasn't the main goal of the studies.⁴
This doesn't mean it isn't safe as a weight loss treatment. However, it does mean that its safety and effectiveness as solely a weight loss drug are not fully understood.
H3: Could Trulicity become a licensed weight loss treatment?
Perhaps. However, it's worth considering that a comparison study has already shown that Wegovy outperforms Trulicity in terms of weight loss.⁵
In the SUSTAIN 7 trial, those receiving the highest tested dose of semaglutide lost 6.5 kg on average. However, those receiving the highest tested dose of dulaglutide – the active ingredient in Trulicity – lost an average of 3kg.
Trulicity is an effective treatment for type 2 diabetes. However, you could argue that there's little point in licensing it for weight loss when more successful treatments like Wegovy are already available.
H3: Access expert-supported, clinically proven weight loss treatments with SemaPen
SemaPen is a weight loss clinic specialising in expert-led
treatments for obesity
. That includes the clinically proven weight loss injections Wegovy and Mounjaro, as well as SemaHealth – our dietitian-led meal replacement and fitness programme.
When you join our programmes, you can expect:
Ready to take the next step on your weight loss journey? You can find out if you're eligible today by taking our simple digital consultation .
Sources
1. Bonora, E. et al. (2021) "Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11" Diabetes Obesity Metabolism , 23(10) https://doi.org/10.1111/dom.14465
2. Wilding, J.P.H. et al. (2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) https://doi.org/10.1056/NEJMoa2032183
3. Jastreboff, A.M. et al. (2022) "Tirzepatide Once Weekly for the Treatment of Obesity" The New England Journal of Medicine, 387(3) https://doi.org/10.1056/NEJMoa2206038
4. Frias, J.P. et al. (2021) "Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)" Diabetes Care , 44(3) https://doi.org/10.2337/dc20-1473
5. Pratley, R.E. et al. (2018) "Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial" The Lancet Diabetes & Endocrinology , 6(4) https://doi.org/10.1016/s2213-8587(18)30024-x
6. Valabhji, J. et al. (2024) "Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation" The Lancet Diabetes & Endocrinology , 12(9) https://doi.org/10.1016/S2213-8587(24)00194-3
This article was reviewed and approved by Lujain Alhassan, Bariatric Dietitian, and Sarah Abdula, Specialist Dietitian, on 3 December 2025.
This doesn't mean it isn't safe as a weight loss treatment. However, it does mean that its safety and effectiveness as solely a weight loss drug are not fully understood.
H3: Could Trulicity become a licensed weight loss treatment?
Perhaps. However, it's worth considering that a comparison study has already shown that Wegovy outperforms Trulicity in terms of weight loss.⁵
In the SUSTAIN 7 trial, those receiving the highest tested dose of semaglutide lost 6.5 kg on average. However, those receiving the highest tested dose of dulaglutide – the active ingredient in Trulicity – lost an average of 3kg.
Trulicity is an effective treatment for type 2 diabetes. However, you could argue that there's little point in licensing it for weight loss when more successful treatments like Wegovy are already available.
H3: Access expert-supported, clinically proven weight loss treatments with SemaPen
SemaPen is a weight loss clinic specialising in expert-led
treatments for obesity
. That includes the clinically proven weight loss injections Wegovy and Mounjaro, as well as SemaHealth – our dietitian-led meal replacement and fitness programme.
When you join our programmes, you can expect:
- Around 21% weight loss with Mounjaro³
- Around 15% weight loss with Wegovy²
- Between 12% and 15% weight loss with SemaHealth⁶
Ready to take the next step on your weight loss journey? You can find out if you're eligible today by taking our simple digital consultation .
Sources
1. Bonora, E. et al. (2021) "Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11" Diabetes Obesity Metabolism , 23(10) https://doi.org/10.1111/dom.14465
2. Wilding, J.P.H. et al. (2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) https://doi.org/10.1056/NEJMoa2032183
3. Jastreboff, A.M. et al. (2022) "Tirzepatide Once Weekly for the Treatment of Obesity" The New England Journal of Medicine, 387(3) https://doi.org/10.1056/NEJMoa2206038
4. Frias, J.P. et al. (2021) "Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)" Diabetes Care , 44(3) https://doi.org/10.2337/dc20-1473
5. Pratley, R.E. et al. (2018) "Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial" The Lancet Diabetes & Endocrinology , 6(4) https://doi.org/10.1016/s2213-8587(18)30024-x
6. Valabhji, J. et al. (2024) "Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation" The Lancet Diabetes & Endocrinology , 12(9) https://doi.org/10.1016/S2213-8587(24)00194-3
This article was reviewed and approved by Lujain Alhassan, Bariatric Dietitian, and Sarah Abdula, Specialist Dietitian, on 3 December 2025.
- Average 15–21% weight loss
- Trusted programmes built by UK experts
- Personalised advice and support
- Smart weight loss app to track progress and learn positive habits
Your journey starts in the app
Unlock tailored support, weight tracking and more.
1
Download the free app
2
Take your digital consultation
3
Start your programme
Have you noticed itchiness when taking Wegovy (semaglutide)? Learn what's normal and when to be concerned.
There's a strong link between obesity and hypertension (high blood pressure). But what causes it? And what can you do to lower your risk?
Mounjaro can be a big helping hand for weight loss – but that doesn't mean you can eat anything and still lose weight. Learn what dieticians recommend.
Several new weight loss treatments are in development, including Amgen's MariTide. Get the key facts about this US-made injectable medication.
Are you considering using Wegovy for weight loss? Read our beginner's guide to get the key information you need in one place.
Did you know that extreme calorie-cutting can make losing weight more difficult? Learn why – and what to do instead.
Clinical trials have shown that Mounjaro is safe and effective as a treatment for obesity and type 2 diabetes. Let's explore their findings in more detail.
Discover more about the FLOW study semaglutide trial, which looked at how Wegovy could lower risks in people with chronic kidney disease.
Excess weight can increase the risk of heart problems. Could Mounjaro injections help? Explore the key findings of the SUMMIT clinical trial.
Weight loss diets have been around since at least the mid-1800s. But does this old-timey advice stand up today? Let's find out.
